Fisher GJ, Kang S, Varani J, et al
The obesity drug development landscape has developed rapidly amid increasing obesity prevalence rates where 40% and above of American adults are categorized as obese and there has been a doubling of obesity cases worldwide between 1975 and today, according to WHO
Vitamin C and E supplementation prevents mitochondrial damage of ileum myocytes caused by intense and exhaustive exercise training
Semaglutide commonly causes nausea, vomiting, and constipation by designslowing digestion is part of how it works
At our clinic, we consider tirzepatide for adults who meet certain criteria: A body mass index (BMI) of 30 or higher (classified as obesity), or A BMI of 27 or higher with at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol Your overall health and medical history are essential in determining if tirzepatide is right for you